News
The FDA approval Is for a 120-person, multi-site, double-blind, randomized, placebo-controlled Phase IIb clinical trial to evaluate the safety and efficacy of L2-01 AD-MSCs in sub ...
Air Evac is setting the gold standard in Arizona , providing specialist emergency 'in-air' perinatal care to the communities of Arizona • Air Evac is Arizona's premier Neonatal ...
Footprints to Recovery, a leading provider of addiction and mental health services, is pleased to announce the launch of its new, private inpatient mental health treatment program at its Elgin, ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced a partnership with Qureight, a ...
Explore how immune system activity, particularly calprotectin levels, may predict early cardiovascular disease risk.
Noted Vaccine Researcher and Leader Kate O'Brien Awarded Sabin's Gold Medal Physician Livancliff Mbianke of Cameroon Receives Rising Star Award ...
Hevin reverses cognitive decline in mice by improving neuronal connections, without affecting amyloid plaque levels.
Targeted liposomes decorated with peptides enhance the efficacy and safety of antifungal treatments against drug-resistant ...
Veterans with depression face a 14% higher risk of heart failure, says a Vanderbilt-led study analyzing over 3.4 million U.S. veterans, urging better depression care.
Embla today announced results from a 64-week real-world study presented at the European Congress on Obesity, tracking nearly 2,700 adults in a digital GLP-1 treatment program. The study found that ...
The new CatSper diagnostic test helps identify undetectable sperm defects, improving infertility treatment outcomes in men with normal semen analysis.
MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results